Navigation Links
FRC Responds to President Obama's Misguided Decision on Stem Cell Science
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to President Barack Obama's decision to abolish limits on federal funding of embryonic stem cell research and urged Congress to renew the Dickey-Wicker Amendment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO)

"Sadly, President Barack Obama has decided to open the door wider to embryonic stem cell research. In his statement today, the President claimed he did not want to make a false choice between 'sound science and moral values.' He does not need to. Adult stem cells have been proven to treat every single disease the President mentioned in his speech today, from Parkinson's to diabetes, heart disease to spinal cord injuries.

"The action by the President today will, in effect, allow scientists to create their own guidelines without proper moral restraints. The President's new policy will allow cloning of human embryos for research. President Obama's executive order shows disrespect for the deeply held moral convictions of tens of millions of Americans by compelling taxpayers to fund this deadly experimentation.

"Congress still has the opportunity to make the ethical choice. I urge Congress to renew the Dickey-Wicker Amendment which will forbid taxpayer funding of the creation of human embryos solely for their destruction. The research that President Obama supports is not sound science and will destroy human life. There is great potential in this country for research and procedures that will cure many diseases and allow us to maintain our ethical standards. I urge Members of Congress to support Dickey-Wicker and focus funding on the proven science of adult stem cells."


'/>"/>
SOURCE Family Research Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
3. GlaxoSmithKline Responds to JAMA Articles
4. Common Good Responds to a Trial Bar Study Opposing Health Courts
5. Consumer Specialty Products Association Responds to European Study Investigating Spray Products and Asthma
6. DuPont Responds to Spelter, W.Va., Lawsuit Decision
7. MARCOR Responds to Deadly MRSA Outbreak
8. The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires
9. Cryolife Victim Responds to Untrue Assertions of Cryolife
10. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
11. Hollywood Presbyterian Medical Center Responds to ACLU Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The Texas ... in recently to the labor and delivery team at Women’s Hospital at Renaissance in ... who give birth at the hospital and decide to donate. , “Women’s Hospital ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: